Single dose typhoid conjugate vaccine (TCV) provides lasting efficacy in children

Published on January 26, 2024

A single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study.

Continue reading on website
Other news

Infants born to COVID-infected mothers have triple the risk of developing respiratory distress

January 24, 2024
Infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they themselves were not infected with the virus, according to a new study. This disorder generally strikes premature infants.

People with Chronic Medical Conditions Continue to Account for The Majority of Flu Hospitalizations This Season

January 26, 2024
CDC posted new data that show the proportion of people hospitalized with flu this season in one CDC surveillance system who also have at least one chronic medical condition.